Cibus, Inc.CBUSEarnings & Financial Report
Cibus, Inc. is a leading agricultural biotechnology firm specializing in precision gene editing technologies to develop improved, sustainable crop traits. Its solutions include herbicide tolerance, disease and pest resistance, and enhanced yield characteristics for major row crops, serving global agricultural markets, seed producers, and farming communities to reduce environmental impact and boost operational efficiency.
Revenue
$933.0K
Gross Profit
N/A
Operating Profit
$-17.9M
Net Profit
$-25.4M
Gross Margin
N/A
Operating Margin
-1923.5%
Net Margin
-2719.4%
YoY Growth
11.3%
EPS
$-0.61
Financial Flow
Cibus, Inc. Q2 2025 Financial Summary
Cibus, Inc. reported revenue of $933.0K (up 11.3% YoY) for Q2 2025, with a net profit of $-25.4M (down 2.0% YoY) (-2719.4% margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $933.0K |
|---|---|
| Net Profit | $-25.4M |
| Gross Margin | N/A |
| Operating Margin | -1923.5% |
| Report Period | Q2 2025 |
Cibus, Inc. Annual Revenue by Year
Cibus, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $3.6M).
| Year | Annual Revenue |
|---|---|
| 2025 | $3.6M |
| 2024 | $4.3M |
| 2023 | $1.8M |
| 2022 | $157.0K |
Cibus, Inc. Quarterly Revenue & Net Profit History
Cibus, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $1.1M | -12.8% | $-31.3M | -2959.9% |
| Q3 2025 | $615.0K | -63.1% | $-23.5M | -3827.8% |
| Q2 2025 | $933.0K | +11.3% | $-25.4M | -2719.4% |
| Q1 2025 | $1.0M | +89.7% | $-46.9M | -4534.4% |
| Q4 2024 | $1.2M | +9.9% | $-23.1M | -1906.1% |
| Q3 2024 | $1.7M | +250.9% | $-180.0M | -10795.9% |
| Q2 2024 | $838.0K | +325.4% | $-24.9M | -2969.3% |
| Q1 2024 | $545.0K | +1197.6% | $-23.4M | -4300.0% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $545000 | $838000 | $1.7M | $1.2M | $1.0M | $933000 | $615000 | $1.1M |
| YoY Growth | 1197.6% | 325.4% | 250.9% | 9.9% | 89.7% | 11.3% | -63.1% | -12.8% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $533.0M | $553.4M | $367.9M | $350.1M | $335.0M | $346.2M | $330.2M | $305.0M |
| Liabilities | $213.2M | $246.3M | $247.0M | $252.2M | $261.1M | $271.7M | $278.2M | $283.2M |
| Equity | $278.2M | $270.5M | $108.1M | $92.2M | $70.3M | $72.1M | $50.4M | $21.8M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-13.5M | $-17.0M | $-13.5M | $-14.0M | $-11.8M | $-13.6M | $-11.7M | $-13.4M |